Post-earnings recap
Reported
Thu, Feb 26, 2026
EPS actual
$2.04
EPS est.
$2.01
EPS surprise
+1.34%
1-day move
-3.34%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported an EPS of $2.04, beating expectations slightly. However, the stock fell by 3.34% in reaction to the earnings report, indicating that investors may have been looking for more comprehensive revenue details or guidance, which were not provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.04 | N/A | +1.34% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.